Human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.

Human parainfluenza virus type 1 (hPIV1) and 3 (hPIV3) cause seasonal epidemics, but little is known about their interaction with human airway cells. In this study, we determined cytopathology, replication, and progeny virion release from human airway cells during long-term infection in vitro. Both...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuki Kurebayashi, Shringkhala Bajimaya, Masahiro Watanabe, Nicholas Lim, Michael Lutz, Megan Dunagan, Toru Takimoto
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/281ac0e84f124cd19fb45c37104a36e9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:281ac0e84f124cd19fb45c37104a36e9
record_format dspace
spelling oai:doaj.org-article:281ac0e84f124cd19fb45c37104a36e92021-12-02T20:00:10ZHuman parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.1553-73661553-737410.1371/journal.ppat.1009908https://doaj.org/article/281ac0e84f124cd19fb45c37104a36e92021-09-01T00:00:00Zhttps://doi.org/10.1371/journal.ppat.1009908https://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Human parainfluenza virus type 1 (hPIV1) and 3 (hPIV3) cause seasonal epidemics, but little is known about their interaction with human airway cells. In this study, we determined cytopathology, replication, and progeny virion release from human airway cells during long-term infection in vitro. Both viruses readily established persistent infection without causing significant cytopathic effects. However, assembly and release of hPIV1 rapidly declined in sharp contrast to hPIV3 due to impaired viral ribonucleocapsid (vRNP) trafficking and virus assembly. Transcriptomic analysis revealed that both viruses induced similar levels of type I and III IFNs. However, hPIV1 induced specific ISGs stronger than hPIV3, such as MX2, which bound to hPIV1 vRNPs in infected cells. In addition, hPIV1 but not hPIV3 suppressed genes involved in lipid biogenesis and hPIV1 infection resulted in ubiquitination and degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, a rate limiting enzyme in cholesterol biosynthesis. Consequently, formation of cholesterol-rich lipid rafts was impaired in hPIV1 infected cells. These results indicate that hPIV1 is capable of regulating cholesterol biogenesis, which likely together with ISGs contributes to establishment of a quiescent infection.Yuki KurebayashiShringkhala BajimayaMasahiro WatanabeNicholas LimMichael LutzMegan DunaganToru TakimotoPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 17, Iss 9, p e1009908 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Yuki Kurebayashi
Shringkhala Bajimaya
Masahiro Watanabe
Nicholas Lim
Michael Lutz
Megan Dunagan
Toru Takimoto
Human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.
description Human parainfluenza virus type 1 (hPIV1) and 3 (hPIV3) cause seasonal epidemics, but little is known about their interaction with human airway cells. In this study, we determined cytopathology, replication, and progeny virion release from human airway cells during long-term infection in vitro. Both viruses readily established persistent infection without causing significant cytopathic effects. However, assembly and release of hPIV1 rapidly declined in sharp contrast to hPIV3 due to impaired viral ribonucleocapsid (vRNP) trafficking and virus assembly. Transcriptomic analysis revealed that both viruses induced similar levels of type I and III IFNs. However, hPIV1 induced specific ISGs stronger than hPIV3, such as MX2, which bound to hPIV1 vRNPs in infected cells. In addition, hPIV1 but not hPIV3 suppressed genes involved in lipid biogenesis and hPIV1 infection resulted in ubiquitination and degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, a rate limiting enzyme in cholesterol biosynthesis. Consequently, formation of cholesterol-rich lipid rafts was impaired in hPIV1 infected cells. These results indicate that hPIV1 is capable of regulating cholesterol biogenesis, which likely together with ISGs contributes to establishment of a quiescent infection.
format article
author Yuki Kurebayashi
Shringkhala Bajimaya
Masahiro Watanabe
Nicholas Lim
Michael Lutz
Megan Dunagan
Toru Takimoto
author_facet Yuki Kurebayashi
Shringkhala Bajimaya
Masahiro Watanabe
Nicholas Lim
Michael Lutz
Megan Dunagan
Toru Takimoto
author_sort Yuki Kurebayashi
title Human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.
title_short Human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.
title_full Human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.
title_fullStr Human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.
title_full_unstemmed Human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.
title_sort human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/281ac0e84f124cd19fb45c37104a36e9
work_keys_str_mv AT yukikurebayashi humanparainfluenzavirustype1regulatescholesterolbiosynthesisandestablishesquiescentinfectioninhumanairwaycells
AT shringkhalabajimaya humanparainfluenzavirustype1regulatescholesterolbiosynthesisandestablishesquiescentinfectioninhumanairwaycells
AT masahirowatanabe humanparainfluenzavirustype1regulatescholesterolbiosynthesisandestablishesquiescentinfectioninhumanairwaycells
AT nicholaslim humanparainfluenzavirustype1regulatescholesterolbiosynthesisandestablishesquiescentinfectioninhumanairwaycells
AT michaellutz humanparainfluenzavirustype1regulatescholesterolbiosynthesisandestablishesquiescentinfectioninhumanairwaycells
AT megandunagan humanparainfluenzavirustype1regulatescholesterolbiosynthesisandestablishesquiescentinfectioninhumanairwaycells
AT torutakimoto humanparainfluenzavirustype1regulatescholesterolbiosynthesisandestablishesquiescentinfectioninhumanairwaycells
_version_ 1718375710652891136